Prenatal vitamin intake may reduce autism recurrence: Study

IANS  |  New York 

Maternal intake of prenatal vitamins, including folic acid, during can significantly lower the risk of spectrum disorder, and lead to higher cognitive skills in younger siblings of children with the neurobehavioural condition, say researchers.

The findings, published in the journal JAMA Psychiatry, could be important for families who have children with and are planning new pregnancies.

It could also imply that genetic susceptibility could potentially be overcome by taking prenatal multivitamins, said researchers from the in the US.

For the study, the team included 241 children from high-risk families and who had a sibling diagnosed with the condition.

Among mothers who took in the first month of pregnancy, only 14.1 per cent (18 children) were born with

Conversely, whose mothers did not take had 32.7 per cent (37 children) with the neurobehavioural condition.

"We found that even though these families are at a likely greater risk for an autism diagnosis for a later sibling due to genetic heritability of ASD, taking during the critical early period contributed to the reduction in autism risk in siblings by about half," said Rebecca J. Schmidt,

"So, in other words, this is about protection against recurrence of ASD in high-risk younger siblings of children with autism," she added.

The study emphasizes the importance of taking prenatal vitamins, including folic acid which is known to reduce the risk for of a baby's brain and spine.

--IANS

rt/mag/bg

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, March 01 2019. 20:02 IST